Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

In the United Kingdom, current screening guidelines for TP53 germline mutation carriers solely recommends annual breast MRI, despite the wide spectrum of malignancies typically seen in this group. This study sought to investigate the role of one-off non-contrast whole-body MRI (WB MRI) in the screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Saya, Sibel, Killick, Emma, Thomas, Sarah, Taylor, Natalie, Bancroft, Elizabeth K., Rothwell, Jeanette, Benafif, Sarah, Dias, Alexander, Mikropoulos, Christos, Pope, Jenny, Chamberlain, Anthony, Gunapala, Ranga, Izatt, Louise, Side, Lucy, Walker, Lisa, Tomkins, Susan, Cook, Jackie, Barwell, Julian, Wiles, Vicki, Limb, Lauren, Eccles, Diana, Leach, Martin O., Shanley, Susan, Gilbert, Fiona J., Hanson, Helen, Gallagher, David, Rajashanker, Bala, Whitehouse, Richard W., Koh, Dow-Mu, Sohaib, S. Aslam, Evans, D. Gareth, Eeles, Rosalind A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487773/
https://www.ncbi.nlm.nih.gov/pubmed/28091804
http://dx.doi.org/10.1007/s10689-017-9965-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487773/
https://www.ncbi.nlm.nih.gov/pubmed/28091804
http://dx.doi.org/10.1007/s10689-017-9965-1

Ejemplares similares